Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 9Phase 1 7Phase NA 4Phase 1/2 4Phase 4 2

Status

Completed 3Withdrawn 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 22Gastrointestinal 14Other solid neoplasm 10Sarcoma 7Tumor-Agnostic 6Breast 6Thoracic 5CNS 5Lymphoid 4Other hematologic neoplasm 3Plasma cell 2Myeloid 2Head & Neck 2Dermatologic 2Gynecologic 1Classical hematology 1

Conditions

Gastrointestinal Stromal Tumors 4Sarcoma 1Osteosarcoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Carcinoma, Renal Cell 1Adenoma, Islet Cell 1

Interventions

Temozolomide 62Cyclophosphamide 59Radiotherapy 47Doxorubicin 36Filgrastim 26Irinotecan 24Radiation 23Gemcitabine 23fludarabine 22Magnetic Resonance Spectroscopy 20Imatinib Mesylate 19Etoposide 18pembrolizumab 16Cisplatin 15Carboplatin 15Biopsy 15Bevacizumab 15Specimen Handling 14fludarabine phosphate 12Nivolumab 12Leucovorin 12Ipilimumab 12Granulocyte Colony-Stimulating Factor 12Chemotherapy, Adjuvant 12pazopanib 11Vincristine 11Ifosfamide 11Melphalan 10Erlotinib Hydrochloride 10Docetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1 × Sunitinib × Sarcoma × Clear all
NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

University of Colorado, Denver

Phase 1 Recruiting
41 enrolled
Sarcoma

Osteosarcoma

NCT05245968 2026-01-20

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Taiho Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
78 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05800106 2023-04-10

A Bioequivalence Study of Sunitinib Malate Capsules.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
24 enrolled
GastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Adenoma, Islet Cell, Gastrointestinal Stromal Tumors

NCT02164240 2021-06-14

SURE

Dana-Farber Cancer Institute

Phase 1 Completed
14 enrolled 8 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03275558 2018-07-19

Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

Center Trials & Treatment

Phase 1 Withdrawn
CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT01498835 2017-08-28

SunRaSe

Heidelberg University

Phase 1 Completed
9 enrolled
Sarcoma

Sarcoma

NCT00573404 2011-11-16

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Vanderbilt-Ingram Cancer Center

Phase 1 Terminated
6 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡